Using real-world evidence to support a changing paradigm for cancer screening: A commentary.
Publication
, Journal Article
Leavy, MB; Starzyk, K; Myers, E; Curhan, G; Gliklich, R
Published in: Pharmacoepidemiol Drug Saf
October 2020
Duke Scholars
Published In
Pharmacoepidemiol Drug Saf
DOI
EISSN
1099-1557
Publication Date
October 2020
Volume
29
Issue
10
Start / End Page
1312 / 1315
Location
England
Related Subject Headings
- Predictive Value of Tests
- Pharmacology & Pharmacy
- Neoplasms
- Mass Screening
- Humans
- Early Detection of Cancer
- Data Collection
- Bias
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Leavy, M. B., Starzyk, K., Myers, E., Curhan, G., & Gliklich, R. (2020). Using real-world evidence to support a changing paradigm for cancer screening: A commentary. Pharmacoepidemiol Drug Saf, 29(10), 1312–1315. https://doi.org/10.1002/pds.5104
Leavy, Michelle B., Kathryn Starzyk, Evan Myers, Gary Curhan, and Richard Gliklich. “Using real-world evidence to support a changing paradigm for cancer screening: A commentary.” Pharmacoepidemiol Drug Saf 29, no. 10 (October 2020): 1312–15. https://doi.org/10.1002/pds.5104.
Leavy MB, Starzyk K, Myers E, Curhan G, Gliklich R. Using real-world evidence to support a changing paradigm for cancer screening: A commentary. Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1312–5.
Leavy, Michelle B., et al. “Using real-world evidence to support a changing paradigm for cancer screening: A commentary.” Pharmacoepidemiol Drug Saf, vol. 29, no. 10, Oct. 2020, pp. 1312–15. Pubmed, doi:10.1002/pds.5104.
Leavy MB, Starzyk K, Myers E, Curhan G, Gliklich R. Using real-world evidence to support a changing paradigm for cancer screening: A commentary. Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1312–1315.
Published In
Pharmacoepidemiol Drug Saf
DOI
EISSN
1099-1557
Publication Date
October 2020
Volume
29
Issue
10
Start / End Page
1312 / 1315
Location
England
Related Subject Headings
- Predictive Value of Tests
- Pharmacology & Pharmacy
- Neoplasms
- Mass Screening
- Humans
- Early Detection of Cancer
- Data Collection
- Bias
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences